Skip to content

Revolution Medicines, Inc.

RVMD· NasdaqCore metricsCIK 1628171

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -2.40%
Market cap
$38.14B
216.29M shares
Filings
871
$197.56M
Q3 2026
-$407.46M
Q3 2026N/M FY25 yoy
-$373.15M
Q3 2026N/M FY25 yoy
-$1.16B
Q3 2026derivedN/M FY25 yoy
-$1.90
Q3 2026N/M FY25 yoy
$615.91M
Q3 2026−29.3% FY25 yoy
$38.14B
—
—
15.9×
-2.40%
—

FY2025 figures · derived

Price

$176.33+175.00%+$112.21past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$50.04M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$11,580,000reported
FY 20222022-12-31$35,380,000reported
FY 20212021-12-31$29,390,000reported
FY 20202020-12-31$42,983,000reported
FY 20192019-12-31$50,041,000reported
FY 20182018-12-31$20,165,000reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2020$0.00—$0.00—73.38M sh+2,129.1%—

Segments

Products
Revenue by Products, FY2018 to FY2022FY2018Collaboration Revenue, Other · FY2018 · $745.00KCollaboration Revenue, Related Party · FY2018 · $19.42MFY2019Collaboration Revenue · FY2019 · $50.04MCollaboration Revenue, Related Party · FY2019 · $50.04MFY2020Collaboration Revenue · FY2020 · $42.98MCollaboration Revenue, Related Party · FY2020 · $42.98MFY2021Collaboration Revenue · FY2021 · $29.39MFY2022Collaboration Revenue · FY2022 · $35.38M
LineFY2022ShareChange
Collaboration Revenue$35.38M100%+20.4%
Collaboration Revenue, Other———
Collaboration Revenue, Related Party———
Total$35.38M

From the 10-K filed Feb 27, 2023RVMD

Biological products, except diagnostic substances

Revolution Medicines, Inc. is the 5th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Revolution Medicines, Inc. · CIK 1628171 · Engraved from SEC EDGAR